Cognitive impairment in patients with multiple sclerosis

Descripción del Articulo

Multiple sclerosis is an inflammatory, autoimmune and neurodegenerative central nervous system disease characterized by motor and sensitive function loss; it is considered to be one of the principal causes of disability in young adults. Recently, cognitive impairment has gain considerable attention...

Descripción completa

Detalles Bibliográficos
Autores: Custodio, Nilton, Montesinos, Rosa, López-Góngora, Mariana
Formato: artículo
Fecha de Publicación:2018
Institución:Universidad Nacional Mayor de San Marcos
Repositorio:Revistas - Universidad Nacional Mayor de San Marcos
Lenguaje:español
OAI Identifier:oai:ojs.csi.unmsm:article/15641
Enlace del recurso:https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/15641
Nivel de acceso:acceso abierto
Materia:Multiple Sclerosis
Central Nervous System
Cognitive Dysfunction
Esclerosis Múltiple
Sistema Nervioso Central
Disfunción Cognitiva
id REVUNMSM_8ad3a4c56acfdf8b98ae67a966742610
oai_identifier_str oai:ojs.csi.unmsm:article/15641
network_acronym_str REVUNMSM
network_name_str Revistas - Universidad Nacional Mayor de San Marcos
repository_id_str
dc.title.none.fl_str_mv Cognitive impairment in patients with multiple sclerosis
Deterioro cognitivo en pacientes con esclerosis múltiple
title Cognitive impairment in patients with multiple sclerosis
spellingShingle Cognitive impairment in patients with multiple sclerosis
Custodio, Nilton
Multiple Sclerosis
Central Nervous System
Cognitive Dysfunction
Esclerosis Múltiple
Sistema Nervioso Central
Disfunción Cognitiva
title_short Cognitive impairment in patients with multiple sclerosis
title_full Cognitive impairment in patients with multiple sclerosis
title_fullStr Cognitive impairment in patients with multiple sclerosis
title_full_unstemmed Cognitive impairment in patients with multiple sclerosis
title_sort Cognitive impairment in patients with multiple sclerosis
dc.creator.none.fl_str_mv Custodio, Nilton
Montesinos, Rosa
López-Góngora, Mariana
author Custodio, Nilton
author_facet Custodio, Nilton
Montesinos, Rosa
López-Góngora, Mariana
author_role author
author2 Montesinos, Rosa
López-Góngora, Mariana
author2_role author
author
dc.subject.none.fl_str_mv Multiple Sclerosis
Central Nervous System
Cognitive Dysfunction
Esclerosis Múltiple
Sistema Nervioso Central
Disfunción Cognitiva
topic Multiple Sclerosis
Central Nervous System
Cognitive Dysfunction
Esclerosis Múltiple
Sistema Nervioso Central
Disfunción Cognitiva
description Multiple sclerosis is an inflammatory, autoimmune and neurodegenerative central nervous system disease characterized by motor and sensitive function loss; it is considered to be one of the principal causes of disability in young adults. Recently, cognitive impairment has gain considerable attention because it is a frequent symptom that causes disability. Cognitive impairment it is present in 40 to 65% of patients and affects speed of information processing, complex attention, working memory, visual and verbal memory, verbal fluency and executive functions. It may be present in radiologically isolated syndrome, clinically isolated syndrome and in the different stages of the disease; it is responsible for patient’s dependence and for the difficulties to maintain or get an employment. Cognitive impairment is associated to thalamic atrophy and a correlation with brain atrophy and cerebral lesional volume has been observed. Different evaluation tools are available, there are 5 minutes short screening tests and comprehensive 90 minutes batteries. Regarding cognitive impairment treatment, there is not a specific pharmacological treatment, nevertheless, disease modifying therapies could have a favorable influence on cognitive function because of their effects in the reduction of inflammatory activity and brain atrophy. There are no conclusive data about the efficacy of cognitive stimulation because of the diverse techniques employed and the different measures used to evaluate the results of the interventions.
publishDate 2018
dc.date.none.fl_str_mv 2018-12-30
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/15641
10.15381/anales.v79i4.15641
url https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/15641
identifier_str_mv 10.15381/anales.v79i4.15641
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/15641/13440
dc.rights.none.fl_str_mv Derechos de autor 2018 Anales de la Facultad de Medicina
https://creativecommons.org/licenses/by-nc-sa/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Derechos de autor 2018 Anales de la Facultad de Medicina
https://creativecommons.org/licenses/by-nc-sa/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana
publisher.none.fl_str_mv Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana
dc.source.none.fl_str_mv Anales de la Facultad de Medicina; Vol. 79 No. 4 (2018); 338-345
Anales de la Facultad de Medicina; Vol. 79 Núm. 4 (2018); 338-345
1609-9419
1025-5583
reponame:Revistas - Universidad Nacional Mayor de San Marcos
instname:Universidad Nacional Mayor de San Marcos
instacron:UNMSM
instname_str Universidad Nacional Mayor de San Marcos
instacron_str UNMSM
institution UNMSM
reponame_str Revistas - Universidad Nacional Mayor de San Marcos
collection Revistas - Universidad Nacional Mayor de San Marcos
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1795238257022205952
spelling Cognitive impairment in patients with multiple sclerosisDeterioro cognitivo en pacientes con esclerosis múltipleCustodio, NiltonMontesinos, RosaLópez-Góngora, MarianaMultiple SclerosisCentral Nervous SystemCognitive DysfunctionEsclerosis MúltipleSistema Nervioso CentralDisfunción CognitivaMultiple sclerosis is an inflammatory, autoimmune and neurodegenerative central nervous system disease characterized by motor and sensitive function loss; it is considered to be one of the principal causes of disability in young adults. Recently, cognitive impairment has gain considerable attention because it is a frequent symptom that causes disability. Cognitive impairment it is present in 40 to 65% of patients and affects speed of information processing, complex attention, working memory, visual and verbal memory, verbal fluency and executive functions. It may be present in radiologically isolated syndrome, clinically isolated syndrome and in the different stages of the disease; it is responsible for patient’s dependence and for the difficulties to maintain or get an employment. Cognitive impairment is associated to thalamic atrophy and a correlation with brain atrophy and cerebral lesional volume has been observed. Different evaluation tools are available, there are 5 minutes short screening tests and comprehensive 90 minutes batteries. Regarding cognitive impairment treatment, there is not a specific pharmacological treatment, nevertheless, disease modifying therapies could have a favorable influence on cognitive function because of their effects in the reduction of inflammatory activity and brain atrophy. There are no conclusive data about the efficacy of cognitive stimulation because of the diverse techniques employed and the different measures used to evaluate the results of the interventions.La esclerosis múltiple es una enfermedad inflamatoria, autoinmune y neurodegenerativa del sistema nervioso central caracterizada por pérdida de la función motora y sensitiva; es considerada una de las principales causas de discapacidad en el adulto joven. Recientemente, se le ha dado gran importancia al deterioro cognitivo, por ser un síntoma frecuente y discapacitante. Este deterioro está presente en un 40 a 65% de los pacientes y afecta la velocidad de procesamiento de información, atención compleja, memoria de trabajo, memoria visual y verbal, fluencia verbal y funciones ejecutivas. Se puede presentar en el síndrome radiológico aislado, en el síndrome clínico aislado y en las diferentes fases de la enfermedad; además, es el responsable de la dependencia de algunos pacientes y de las dificultades para mantener o conseguir empleo. Este déficit cognitivo se asocia a atrofia del tálamo y se ha observado una correlación con las medidas de atrofia y con el volumen lesional cerebral. Existen diferentes herramientas para su evaluación; hay pruebas de cribado breves de 5 minutos de duración, hasta baterías extensas de 90 minutos. Respecto al tratamiento de las alteraciones cognitivas, no existe un tratamiento farmacológico específico; sin embargo, se considera que los fármacos modificadores de la enfermedad podrían tener una influencia favorable en la función cognitiva por sus efectos en la reducción de la actividad inflamatoria y la atrofia cerebral. En cuanto a la estimulación cognitiva, no existen datos concluyentes por las diferentes técnicas empleadas y las distintas medidas utilizadas para evaluar los resultados de las intervenciones.Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana2018-12-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/1564110.15381/anales.v79i4.15641Anales de la Facultad de Medicina; Vol. 79 No. 4 (2018); 338-345Anales de la Facultad de Medicina; Vol. 79 Núm. 4 (2018); 338-3451609-94191025-5583reponame:Revistas - Universidad Nacional Mayor de San Marcosinstname:Universidad Nacional Mayor de San Marcosinstacron:UNMSMspahttps://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/15641/13440Derechos de autor 2018 Anales de la Facultad de Medicinahttps://creativecommons.org/licenses/by-nc-sa/4.0info:eu-repo/semantics/openAccessoai:ojs.csi.unmsm:article/156412019-01-18T09:35:14Z
score 13.932913
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).